A Risk Score to Predict the Absence of Left Ventricular Reverse Remodelling: Implications for the Timing of ICD Implantation in Primary Prevention
- PMID: 30416569
- PMCID: PMC6213222
- DOI: 10.15420/ecr.2017:23:8
A Risk Score to Predict the Absence of Left Ventricular Reverse Remodelling: Implications for the Timing of ICD Implantation in Primary Prevention
Keywords: Heart failure; implantable cardioverter defibrillator; left ventricular reverse remodelling; pharmacological treatment optimization; risk score.
References
-
- Bristow MR, Gilbert EM, Abraham WT et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation. 1996;94:2807–16. - PubMed
-
- Lupón J, Gaggin HK, De Antonio M et al. Biomarker-assist score for reverse remodeling prediction in heart failure: The ST2-R2 score. Int J Cardiol. 2015;184:337–43. - PubMed
LinkOut - more resources
Full Text Sources
